BHIVA treatment guidelines for tuberculosis (TB)/HIV infection 2005

被引：43

作者：

Pozniak, AL

Miller, RF

Lipman, MCI

Freedman, AR

Ormerod, LP

Johnson, MA

Collins, S

Lucas, SB

机构：

[1] Chelsea & Westminster Hosp, London SW10 974, England

[2] UCL, Royal Free & Univ Coll Med Sch, Ctr Sexual Hlth & HIV Res, Dept Primary Care & Populat Sci, London, England

[3] Royal Free Hosp, London NW3 2QG, England

[4] Cardiff Univ, Sch Med, Cardiff, Wales

[5] Blackburn Royal Infirm, Blackburn, Lancs, England

[6] HIV iBase, London, England

[7] St Thomas Hosp, GKT Sch Med, Dept Histopathol, London, England

来源：

HIV MEDICINE | 2005年 / 6卷

关键词：

D O I：

10.1111/j.1468-1293.2005.00293.x

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

[No abstract available]

引用

页码：62 / 83

页数：22

共 133 条

[61] TUBERCULIN SKIN-TEST REACTIVITY AMONG ADULTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS [J].

JOHNSON, MP ;

COBERLY, JS ;

CLERMONT, HC ;

CHAISSON, RE ;

DAVIS, HL ;

LOSIKOFF, P ;

RUFF, AJ ;

BOULOS, R ;

HALSEY, NA .

JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (01) :194-198

[62] RELATIONSHIP OF THE MANIFESTATIONS OF TUBERCULOSIS TO CD4 CELL COUNTS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].

JONES, BE ;

YOUNG, SMM ;

ANTONISKIS, D ;

DAVIDSON, PT ;

KRAMER, F ;

BARNES, PF .

AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (05) :1292-1297

[63]

Jones JL, 2000, INT J TUBERC LUNG D, V4, P1026

[64] ISONIAZID AS PREVENTIVE THERAPY IN HIV-INFECTED INTRAVENOUS DRUG-ABUSERS - A DECISION-ANALYSIS [J].

JORDAN, TJ ;

LEWIT, EM ;

MONTGOMERY, RL ;

REICHMAN, LB .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (22) :2987-2991

[65] Highly active antiretroviral therapy for HIV with tuberculosis - Pardon the granuloma [J].

Judson, MA .

CHEST, 2002, 122 (02) :399-400

[66]

KARMOLTRATANAKU.C, 1999, T R SOC TROP MED HYG, V93, P552

[67] 2-YEAR FOLLOW-UP OF PERSONS WITH HIV-1-ASSOCIATED AND HIV-2-ASSOCIATED PULMONARY TUBERCULOSIS TREATED WITH SHORT-COURSE CHEMOTHERAPY IN WEST-AFRICA [J].

KASSIM, S ;

SASSANMOROKRO, M ;

ACKAH, A ;

ABOUYA, LY ;

DIGBEU, H ;

YESSO, G ;

COULIBALY, IM ;

COULIBALY, D ;

WHITAKER, PJ ;

DOORLY, R ;

VETTER, KM ;

BRATTEGAARD, K ;

GNAORE, E ;

GREENBERG, AE ;

WIKTOR, SZ ;

DECOCK, KM .

AIDS, 1995, 9 (10) :1185-1191

[68] Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis [J].

Kennedy, N ;

Berger, L ;

Curram, J ;

Fox, R ;

Gutmann, J ;

Kisyombe, GM ;

Ngowi, FI ;

Ramsay, ARC ;

Saruni, AOS ;

Sam, N ;

Tillotson, G ;

Uiso, LO ;

Yates, M ;

Gillespie, SH .

CLINICAL INFECTIOUS DISEASES, 1996, 22 (05) :827-833

[69] The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors [J].

Kim, RB ;

Fromm, MF ;

Wandel, C ;

Leake, B ;

Wood, AJJ ;

Roden, DM ;

Wilkinson, GR .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :289-294

[70] IDENTIFICATION OF RIFAMPIN-INDUCIBLE P450IIIA4 (CYP3A4) IN HUMAN SMALL-BOWEL ENTEROCYTES [J].

KOLARS, JC ;

SCHMIEDLINREN, P ;

SCHUETZ, JD ;

FANG, C ;

WATKINS, PB .

JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (05) :1871-1878

← 2 3 4 5 6 7 8 9 10 11 →